The growing interest in effective weight management has led to considerable research into cutting-edge treatments. Recently , Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist , has shown promising results in medical trials, suggesting potential for substantial weight